Resverlogix Corp. (RVX.TO)

CAD 0.04

(-11.11%)

Inventory Summary of Resverlogix Corp.

  • Resverlogix Corp.'s latest annual inventory in 2022 was 2.37 Million USD , down -3.34% from previous year.
  • Resverlogix Corp.'s latest quarterly inventory in 2023 Q2 was 2.37 Million USD , up 99900.0% from previous quarter.
  • Resverlogix Corp. reported annual inventory of 2.45 Million USD in 2021, up 419934.25% from previous year.
  • Resverlogix Corp. reported annual inventory of 584.00 USD in 2020, down -99.96% from previous year.
  • Resverlogix Corp. reported quarterly inventory of 2.37 Million USD for 2023 Q2, up 99900.0% from previous quarter.
  • Resverlogix Corp. reported quarterly inventory of 2.37 Million USD for 2023 Q3, down 0.0% from previous quarter.

Annual Inventory Chart of Resverlogix Corp. (2022 - 2001)

Historical Annual Inventory of Resverlogix Corp. (2022 - 2001)

Year Inventory Inventory Growth
2022 2.37 Million USD -3.34%
2021 2.45 Million USD 419934.25%
2020 584.00 USD -99.96%
2019 1.55 Million USD 34.34%
2018 1.15 Million USD -62.17%
2017 3.05 Million USD -8.59%
2016 3.34 Million USD 80.8%
2015 1.84 Million USD 474.22%
2014 322 Thousand USD 40.0%
2013 230 Thousand USD 2.22%
2012 225 Thousand USD -72.15%
2011 808 Thousand USD -18.99%
2010 997.39 Thousand USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%

Peer Inventory Comparison of Resverlogix Corp.

Name Inventory Inventory Difference
Appili Therapeutics Inc. - CAD -Infinity%
Eupraxia Pharmaceuticals Inc. 1.00 CAD -237099900.0%
Helix BioPharma Corp. - CAD -Infinity%
Microbix Biosystems Inc. 5.75 Million CAD 58.78%
Medicenna Therapeutics Corp. - CAD -Infinity%
Satellos Bioscience Inc. -583 Thousand CAD 506.69%
Oncolytics Biotech Inc. - CAD -Infinity%
Sernova Corp. - CAD -Infinity%